Arbutus Biopharma Corporation ABUS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's change in other assets?
- Arbutus Biopharma Corporation (ABUS) reported change in other assets of $195K in Q1 2026.
- How has Arbutus Biopharma Corporation's change in other assets changed year-over-year?
- Arbutus Biopharma Corporation's change in other assets increased by 147.2% year-over-year, from -$413K to $195K.
- What is the long-term trend for Arbutus Biopharma Corporation's change in other assets?
- Over 2 years (2022 to 2025), Arbutus Biopharma Corporation's change in other assets has grown at a -16.4% compound annual growth rate (CAGR), from -$2.43M to -$1.7M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.